CLINICAL_TRIALS
trial_result
· 2012-05-31
Clinical Trial Update: Antiviral Activity of Entecavir in Patients Receiving Liver Transplant Due to Chronic Hepatitis B Virus Infection [Phase 3]
Summary
Phase 3 trial evaluating antiviral activity of entecavir in liver transplant recipients with chronic hepatitis B; results have been posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Bristol-Myers Squibb | Conditions: Hepatitis B, Chronic | Phase 3 | Status: COMPLETED | Results posted: 2012-05-31